Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» V114
V114
Merck, locked in next-gen pneumococcal vaccine race with Pfizer, strengthens its lead in childhood use
Fierce Pharma
Thu, 05/20/21 - 12:25 pm
Merck
Pfizer
pneumococcal disease
vaccines
V114
Merck snags priority review for Prevnar 13 rival — just one month after Pfizer sent its follow-on to the FDA
Endpoints
Tue, 01/12/21 - 10:59 am
Merck
V114
pneumococcal disease
vaccines
FDA
priority review
Prevnar 13
Pfizer
Merck's rival to Pfizer's Prevnar 13 hits goal in phase 3 again
Fierce Biotech
Tue, 10/20/20 - 10:38 am
Merck
Pfizer
vaccines
Prevnar 13
clinical trials
V114
pneumococcal disease
Merck’s pneumonia vaccine posts two more hits
EP Vantage
Wed, 09/9/20 - 11:04 am
Merck
vaccines
V114
Pfizer
Prevnar 13
Merck’s Experimental Pneumonia Vaccine Hits the Mark in Two Phase III Studies
BioSpace
Mon, 06/22/20 - 08:38 pm
Merck
vaccines
V114
clinical trials
HIV
pneumonia
pneumococcal disease
Looking to topple Pfizer's Prevnar 13 dynasty, Merck claims another win for its 'breakthrough' pneumococcal conjugate vaccine
Endpoints
Wed, 05/8/19 - 12:30 pm
Merck
Pfizer
vaccines
pneumococcal disease
V114
Prevnar 13
FDA
FDA blesses Merck’s PhIII effort to topple a mega-blockbuster — but there’s also a little biotech in this game
Endpoints
Thu, 01/31/19 - 11:27 am
Merck
V114
vaccines
FDA
breakthrough status
Prevnar 13
Pfizer
Merck pits its pneumococcal shot against Pfizer's mammoth Prevnar in head-to-head ph3
Fierce Pharma
Wed, 04/18/18 - 09:50 am
Merck
pneumococcal disease
V114
Pfizer
Prevnar 13
Merck CEO: Gardasil plus pipeline equals big things ahead for vaccines
Fierce Pharma
Mon, 06/12/17 - 09:47 am
Merck
Pharma CEOs
Ken Frazier
vaccines
Gardasil
V114
Moderna Therapeutics